Novartis AG (NVS) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Novartis Ag.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.179 Good morning and good afternoon and welcome to the Novartis Q1 2026 Results Release 00:00:05.179 -- 00:00:10.007 Conference Call and Live Webcast. Please note that during the presentation, all participants 00:00:10.007 -- 00:00:13.353 will be in a listen-only mode and the conference is being recorded. 00:00:13.353 -- 00:00:17.981 After the presentation, there'll be an opportunity to ask questions by pressing star 00:00:17.981 -- 00:00:21.086 1 and 1 at any time during the conference. 00:00:21.086 -- 00:00:25.428 Please limit yourselves to one question and return to the queue for any follow-ups. 00:00:25.428 -- 00:00:29.794 A recording of the conference call, including the Q&A session, will be available on our 00:00:29.794 -- 00:00:34.161 website shortly after the call ends. With that, I would like to hand over to Ms. 00:00:34.161 -- 00:00:36.544 Sloane Simpson, Head of Investor Relations. 00:00:36.544 -- 00:00:39.569 Please go ahead, Madam. Thank you, Sharon. 00:00:39.569 -- 00:00:44.616 Good morning and good afternoon, and welcome to everyone to our Q1 2026 conference 00:00:44.616 -- 00:00:49.603 call. The information presented today contains forward-looking statements that involve 00:00:49.603 -- 00:00:53.626 known and unknown risks, uncertainties, and other factors. 00:00:53.626 -- 00:00:58.110 These may cause actual results to be materially different from any future results, performance, 00:00:58.110 -- 00:01:01.713 or achievements expressed or implied by such statements. 00:01:01.713 -- 00:01:06.437 For a description of some of these factors, please refer to the company's Form 20-F and 00:01:06.437 -- 00:01:11.742 its most recent quarterly results on Form 6-K that respectively were filed with and furnished 00:01:11.742 -- 00:0...